Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.600
-0.200 (-5.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LIXT Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -6.01 | -3.59 | -5.09 | -6.31 | -6.73 | |
| Stock-Based Compensation | 1.56 | 0.42 | 0.77 | 1.55 | 2.6 | |
| Other Operating Activities | 0.97 | - | - | - | - | |
| Change in Accounts Payable | 0.38 | -0.07 | -0.07 | 0 | 0.04 | |
| Change in Unearned Revenue | -0 | 0.08 | -0.01 | 0.09 | 0.06 | |
| Change in Other Net Operating Assets | 0.04 | -0 | 0.1 | 0.06 | -0.11 | |
| Operating Cash Flow | -3.07 | -3.16 | -4.29 | -4.61 | -4.14 | |
| Capital Expenditures | -0.1 | - | - | - | - | |
| Investment in Securities | -0.44 | - | - | - | - | |
| Other Investing Activities | -2.64 | - | - | - | - | |
| Investing Cash Flow | -3.17 | - | - | - | - | |
| Issuance of Common Stock | 11.18 | - | 3.51 | 5.14 | 3.91 | |
| Other Financing Activities | -0.87 | - | -0.36 | - | -0.01 | |
| Financing Cash Flow | 10.31 | - | 3.14 | 5.14 | 3.9 | |
| Net Cash Flow | 4.07 | -3.16 | -1.15 | 0.53 | -0.25 | |
| Free Cash Flow | -3.17 | -3.16 | -4.29 | -4.61 | -4.14 | |
| Free Cash Flow Per Share | -0.65 | -1.41 | -2.24 | -2.92 | -3.08 | |
| Cash Interest Paid | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Levered Free Cash Flow | -1.28 | -1.82 | -2.4 | -2.25 | -1.63 | |
| Unlevered Free Cash Flow | -1.27 | -1.81 | -2.39 | -2.24 | -1.63 | |
| Change in Working Capital | 0.41 | 0 | 0.02 | 0.15 | -0.01 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.